Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for QHSLab Inc. (USAQ : OTC)

• Company Description    QHSLab, Inc. is a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians. Digital healthcare allows doctors to remotely monitor patients' vital signs and evaluate the effects of prescribed medicines and treatments on patients' health through real-time data transferred from patient to doctor. The company also markets and sells point-of-care, rapid-response diagnostic tests used in the primary care practice. The company changed its name to QHSLab from USA Equities Corp. in April 2022. Number of Employees: 5

• Price / Volume Information    Yesterday's Closing Price: $0.40 Daily Weekly Monthly 20 Day Moving Average: 5,090 shares Shares Outstanding: 8.76 (millions) Market Capitalization: $3.50 (millions) Beta: -1.47 52 Week High: $1.00 52 Week Low: $0.30 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -27.22% -18.04% 12 Week -11.09% -2.26% Year To Date -45.18% -43.26%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 901 NORTHPOINT PARKWAY SUITE 302 - WEST PALM BEACH,FL 33407 USA ph: 929-379-6503 fax: - ir@usaqcorp.com http://www.usaqcorp.com

• General Corporate Information    Officers Troy Grogan - Chief Executive Officer; Chief Financial Officer Troy Grogan - Chief Financial Officer - - - - - - - - - Peer Information QHSLab Inc. (CORR.) QHSLab Inc. (RSPI) QHSLab Inc. (CGXP) QHSLab Inc. (BGEN) QHSLab Inc. (GTBP) QHSLab Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 90350R107 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/21 Next Expected EPS Date: - Share - Related Items Shares Outstanding: 8.76 Most Recent Split Date: 5.00 (0.01:1) Beta: -1.47 Market Capitalization: $3.50 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.02 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.04 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 5.19 Price/Cash Flow: - Price / Sales: 2.39 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -50.00% Sales Growth vs. Year Ago Period: 16.78% vs. Previous Quarter: 7.58% ROE 03/31/22 - -0.60 12/31/21 - -0.53 09/30/21 - -0.41 ROA 03/31/22 - -0.14 12/31/21 - -0.13 09/30/21 - -0.10 Current Ratio 03/31/22 - 0.38 12/31/21 - 0.51 09/30/21 - 0.82 Quick Ratio 03/31/22 - - 12/31/21 - 0.43 09/30/21 - 0.70 Operating Margin 03/31/22 - -59.57 12/31/21 - -54.39 09/30/21 - -49.03 Net Margin 03/31/22 - -59.57 12/31/21 - -54.39 09/30/21 - -49.03 Pre-Tax Margin 03/31/22 - -59.59 12/31/21 - -54.46 09/30/21 - -49.05 Book Value 03/31/22 - 0.08 12/31/21 - 0.09 09/30/21 - 67.34 Inventory Turnover 03/31/22 - 0.03 12/31/21 - 0.03 09/30/21 - 0.03 Debt-to-Equity 03/31/22 - 0.68 12/31/21 - 0.61 09/30/21 - 1.49 Debt-to-Capital 03/31/22 - 40.39 12/31/21 - 37.90 09/30/21 - 59.86

Powered by Zacks Investment Research ©